{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:11:18Z","timestamp":1779927078760,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Danish Regions' \u201cMedicinpuljen\u201d"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s40262-019-00838-1","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:03:43Z","timestamp":1574136223000},"page":"643-654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-6158","authenticated-orcid":false,"given":"Christina","family":"Gade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sverrisd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Dalhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Sonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia \u00d8stergaard","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Rolighed","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Burhenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Mikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Christian","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine Meldgaard","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"838_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4155\/cli.14.101","volume":"4","author":"P Auby","year":"2014","unstructured":"Auby P. The European Union pediatric legislation: impact on pharmaceutical research in pediatric populations. Clin Invest (Lond). 2014;4:1013\u20139.","journal-title":"Clin Invest (Lond)."},{"issue":"5","key":"838_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","volume":"51","author":"MJE Brill","year":"2012","unstructured":"Brill MJE, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe PCAJ. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51(5):277\u2013304.","journal-title":"Clin Pharmacokinet."},{"issue":"1","key":"838_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.18773\/austprescr.2017.005","volume":"40","author":"R Smith","year":"2017","unstructured":"Smith R, Brown J. Midazolam for status epilepticus. Aust Prescr. 2017;40(1):23\u20135.","journal-title":"Aust Prescr."},{"issue":"4","key":"838_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s100720200058","volume":"23","author":"H Ulvi","year":"2002","unstructured":"Ulvi H, Yoldas T, M\u00fcngen B, Yigiter R. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurol Sci. 2002;23(4):177\u201382.","journal-title":"Neurol Sci."},{"key":"838_CR5","unstructured":"World Health Organization. Epilepsy. 2018. http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/epilepsy. Accessed 30 Apr 2018."},{"key":"838_CR6","unstructured":"Danish Paediatric Society. Status epilepticus. 2019. http:\/\/www.paediatri.dk\/images\/dokumenter\/vejledninger_2017\/Status_instruks_DPS_Rettelse_090917.pdf. Accessed 30 Jan 2019."},{"key":"838_CR7","unstructured":"NKR: Ny retningslinje om udredning og behandling af epilepsi hos b\u00f8rn og unge. 2019. https:\/\/www.sst.dk\/da\/nyheder\/2015\/nkr-ny-retningslinje-om-udredning-og-behandling-af-epilepsi-hos-boern-og-unge. Accessed 13 Feb 2019."},{"issue":"4","key":"838_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2125.2009.03591.x","volume":"70","author":"M Cella","year":"2010","unstructured":"Cella M, Knibbe C, Danhof M, Della Pasqua O. What is the right dose for children? Br J Clin Pharmacol. 2010;70(4):597\u2013603.","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"838_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/adc.2009.163055","volume":"95","author":"H Mulla","year":"2010","unstructured":"Mulla H, Johnson TN. Dosing dilemmas in obese children. Arch Dis Child Educ Pract Ed. 2010;95(4):112\u20137.","journal-title":"Arch Dis Child Educ Pract Ed."},{"key":"838_CR10","unstructured":"Committee for Medicinal Products for Human Use (CHMP). European Medicines Agency: EMA\/662938\/2011 - Assessment report of Buccolam. 2011;44."},{"key":"838_CR11","unstructured":"DrugBank. Midazolam. 2018. https:\/\/www.drugbank.ca\/drugs\/DB00683. Accessed 3 May 2018."},{"issue":"1","key":"838_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341.","journal-title":"Pharmacol Ther."},{"issue":"5","key":"838_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/bcp.12693","volume":"80","author":"A van Rongen","year":"2015","unstructured":"van Rongen A, Vaughns JD, Moorthy GS, Barrett JS, Knibbe CAJ, van den Anker JN. Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents. Br J Clin Pharmacol. 2015;80(5):1185\u201396.","journal-title":"Br J Clin Pharmacol."},{"issue":"10","key":"838_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","volume":"53","author":"MJE Brill","year":"2014","unstructured":"Brill MJE, van Rongen A, Houwink API, Burggraaf J, van Ramshorst B, Wiezer RJ. Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers. Clin Pharmacokinet. 2014;53(10):931\u201341.","journal-title":"Clin Pharmacokinet."},{"issue":"12","key":"838_CR15","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s11095-015-1752-9","volume":"32","author":"MJ Brill","year":"2015","unstructured":"Brill MJ, van Rongen A, van Dongen EP, van Ramshorst B, Hazebroek EJ, Darwich AS. The pharmacokinetics of the CYP3A substrate midazolam in morbidly obese patients before and one year after bariatric surgery. Pharm Res. 2015;32(12):3927\u201336.","journal-title":"Pharm Res."},{"issue":"5","key":"838_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40262-017-0579-4","volume":"57","author":"A van Rongen","year":"2018","unstructured":"van Rongen A, Brill MJE, Vaughns JD, V\u00e4litalo PAJ, van Dongen EPA, van Ramshorst B, et al. Higher midazolam clearance in obese adolescents compared with morbidly obese adults. Clin Pharmacokinet. 2018;57(5):601\u201311.","journal-title":"Clin Pharmacokinet."},{"issue":"8","key":"838_CR17","doi-asserted-by":"publisher","first-page":"e0135018","DOI":"10.1371\/journal.pone.0135018","volume":"10","author":"CE Fonvig","year":"2015","unstructured":"Fonvig CE, Chabanova E, Andersson EA, Ohrt JD, Pedersen O, Hansen T. 1H-MRS measured ectopic fat in liver and muscle in Danish lean and obese children and adolescents. PLoS One. 2015;10(8):e0135018.","journal-title":"PLoS One."},{"issue":"5","key":"838_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11936-006-0045-3","volume":"8","author":"GK Singh","year":"2006","unstructured":"Singh GK. Metabolic syndrome in children and adolescents. Curr Treat Options Cardiovasc Med. 2006;8(5):403\u201313.","journal-title":"Curr Treat Options Cardiovasc Med."},{"issue":"2","key":"838_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bcp.12502","volume":"79","author":"N Hohmann","year":"2015","unstructured":"Hohmann N, Kocheise F, Carls A, Burhenne J, Haefeli WE, Mikus G. Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans. Br J Clin Pharmacol. 2015;79(2):278\u201385.","journal-title":"Br J Clin Pharmacol."},{"key":"838_CR20","first-page":"5","volume":"63","author":"C Gade","year":"2016","unstructured":"Gade C, Mikus G, Christensen HR, Dalhoff KP, Holm J-C, Holst H. The CYTONOX trial. Dan Med J. 2016;63:5.","journal-title":"The CYTONOX trial. Dan Med J."},{"key":"838_CR21","doi-asserted-by":"crossref","unstructured":"E-Tidsskrifter. Higher chlorzoxazone clearance in obese children compared with nonobese peers. 2018. https:\/\/e-tidsskrifter.kb.dk\/resolve?sid=google&auinit=C&aulast=Gade&atitle=Higher+chlorzoxazone+clearance+in+obese+children+compared+with+nonobese+peers&id=doi:10.1111\/bcp.13602. Accessed 8 Oct 2018.","DOI":"10.1111\/bcp.13602"},{"issue":"2","key":"838_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.ijo.0801515","volume":"25","author":"K Nysom","year":"2001","unstructured":"Nysom K, M\u00f8lgaard C, Hutchings B, et al. Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values. Int J Obes Relat Metab Disord. 2001;25(2):177\u201384.","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"7","key":"838_CR23","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s00216-011-5675-y","volume":"402","author":"J Burhenne","year":"2012","unstructured":"Burhenne J, Halama B, Maurer M, Riedel K-D, Hohmann N, Mikus G. Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1\u2032-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry. Anal Bioanal Chem. 2012;402(7):2439\u201350.","journal-title":"Anal Bioanal Chem."},{"issue":"10","key":"838_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/sim.4780111005","volume":"11","author":"TJ Cole","year":"1992","unstructured":"Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992;11(10):1305\u201319.","journal-title":"Stat Med."},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","volume":"101","author":"RJ Keizer","year":"2011","unstructured":"Keizer RJ, et al. Pirana and PCluster: a modeling environment and cluster infrastucture for NONMEM. Comput Methods Programs Biomed. 2011;101:72\u20139","journal-title":"Comput Methods Programs Biomed."},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1038\/psp.2012.4","volume":"1","author":"DR Mould","year":"2012","unstructured":"Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharmacomet Syst Pharmacol. 2012;1:e6.","journal-title":"CPT Pharmacomet Syst Pharmacol."},{"issue":"3","key":"838_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-2125.1998.00781.x","volume":"46","author":"R Schwagmeier","year":"1998","unstructured":"Schwagmeier R, Alincic S, Striebel HW. Midazolam pharmacokinetics following intravenous and buccal administration. Br J Clin Pharmacol. 1998;46(3):203\u20136.","journal-title":"Br J Clin Pharmacol."},{"issue":"8","key":"838_CR28","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/bcp.13602","volume":"84","author":"C Gade","year":"2018","unstructured":"Gade C, Dalhoff K, Petersen TS, Riis T, Schmeltz C, Chabanova E. Higher chlorzoxazone clearance in obese children compared with nonobese peers. Br J Clin Pharmacol. 2018;84(8):1738\u201347.","journal-title":"Br J Clin Pharmacol."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-019-00838-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:46:20Z","timestamp":1605656780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-019-00838-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s40262-019-00838-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736952458.793568265","asserted-by":"object"}]},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"19 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study was funded by the Danish Regions\u2019 \u201cMedicinpuljen\u201d. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Christina Gade, Mia \u00d8stergaard Johansen, Eva Sverrisd\u00f3ttir, Kim Dahloff, Hanne Rolighed Christensen, Gerd Mikus, Jesper Sonne, J\u00fcrgen Burhenne, Jens Christian Holm, Trine Meldgaard Lund and Helle Holst declare that they have no potential conflicts of interest that might be relevant to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}